IBM Aspera Faspex XML external entity injection
CVE-2023-27874

9.9CRITICAL

Key Information:

Vendor

IBM
Status
Aspera Faspex
Vendor
CVE Published:
21 March 2023

What is CVE-2023-27874?

IBM Aspera Faspex 4.4.2 is susceptible to an XML external entity injection (XXE) vulnerability, allowing remote authenticated attackers to manipulate XML data processing. This exploitation may enable unauthorized execution of arbitrary commands on the server, posing significant security risks to users and their data. Proper attention to security practices is essential to mitigate the effects of this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Aspera Faspex 4.4.2

References

https://www.ibm.com/support/pages/node/6964694
vendor-advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/249845
vdb-entry

CVSS V3.1

Score:
9.9
Severity:
CRITICAL
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.